Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.12T, Eli Lilly(LLY) trades at $1,190.42. The stock has a price-to-earnings ratio of 39.33 and currently yields dividends of 0.58%.
During the trading session on 2026-10-07, Eli Lilly(LLY) shares reached a daily high of $1,191.23 and a low of $1,162.69. At a current price of $1,190.42, the stock is +2.4% higher than the low and still -0.1% under the high.
Trading activity shows a volume of 629.28K, compared to an average daily volume of 2.19M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
Eli Lilly received an expanded FDA approval for Jaypirca, allowing first-line use in adults with previously untreated CLL or SLL without a known 17p deletion, b...
Investing Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound Eli Lilly's two blockbuster drug approvals that transformed the company...
Clean energy has been hot for years, but the truth is that the global economy still runs on carbon fuels like oil and natural gas. With the geopolitical conflic...
Analyst ratings
84%
of 32 ratingsMore LLY News
In the latest close session, Eli Lilly (LLY Quick QuoteLLY - Free Report) was up +1.26% at $1,157.49. The stock's change was more than the S&P 500's daily...
Eli Lilly built its reputation on weight loss drugs, but a fast-growing portfolio in oncology, immunology, and neuroscience just posted triple-digit gains, and...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This Phase 1 study, officially titled “A Phase 1, Open-Label, Single Dose Stud...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) has completed a Phase 1 trial titled “A Four-Part,...
The race for dominance in weight-loss and diabetes treatments has reached a fever pitch. Investors choosing between Eli Lilly and (LLY +0.02%) and Novo Nordisk...
Eli Lilly (LLY) just expanded its collaboration with Gate Bioscience to pursue additional molecular gate therapeutics, a research heavy area that often attracts...
Eli Lilly (LLY +0.02%) is the only healthcare stock in the trillion-dollar club, and for good reason. Its business has been booming due to its successful GLP-1...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.